:::°æÈñ´ëÇб³ ÇÑÀÇ°ú´ëÇÐ ¾Ï¿¹¹æ¼ÒÀç°³¹ß¿¬¼ö¼¾ÅÍ¿¡ ¿À½Å°ÍÀ» ȯ¿µÇÕ´Ï´Ù:::
:::°æÈñ´ëÇб³ ÇÑÀÇ°ú´ëÇÐ ¾Ï¿¹¹æ¼ÒÀç°³¹ß¿¬¼ö¼¾ÅÍ¿¡ ¿À½Å°ÍÀ» ȯ¿µÇÕ´Ï´Ù:::
¡¡
¡¡
   
  Silencing of HSulf-2 expression in MCF10DICS.com cells attenuate ductal carcinoma in situ progression to invasive ductal carcinoma in vivo.
  ±Û¾´ÀÌ : ÃÖ°í°ü¸®ÀÚ     ³¯Â¥ : 12-04-23 14:49     Á¶È¸ : 2312    
   2012-26.pdf (1.5M), Down : 21, 2012-04-23 14:49:12
Ashwani Khurana1, Hiedi McKean1, Hyunseok Kim2, Sung-Hoon Kim2, Jacie Mcguire1, Lewis R
Roberts3, Matthew P Goetz4 and Viji Shridhar1
1. Department of Experimental Pathology, Mayo Clinic College of Medicine, 200 First
Street SW, Rochester, MN 55905, USA.
2. Cancer Preventive Material Development Research Center (CPMDRC) and Institute,
College of Oriental Medicine, Kyunghee University, Dongdaemun-gu, Seoul 130-701,
South Korea.
3. Section of Gastroenterology, Mayo Clinic College of Medicine, 200 First Street SW,
Rochester, MN 55905, USA.
4. Department of Oncology, Mayo Clinic College of Medicine, 200 First Street SW,
Rochester, MN 55905, USA.

   

:::°æÈñ´ëÇб³ ÇÑÀÇ°ú´ëÇÐ ¾Ï¿¹¹æ¼ÒÀç°³¹ß¿¬¼ö¼¾ÅÍ¿¡ ¿À½Å°ÍÀ» ȯ¿µÇÕ´Ï´Ù:::